This is a preview of subscription content, log in via an institution to check access.
References
1 Maton PN: Omeprazole. N Engl J Med 324:965–75, 1991
2 Nelis GF: Safety profile of omeprazole: adverse events with short-term treatment. Digestion 44(Suppl 1):68–76, 1989
3 Brunner GHG, Lamberts R, Creutzfeld W: Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. Digestion 47:64–68, 1990
4 Havelund T, Horing H, Boerby S, et al.: Omeprazole improves outcome in peptic ulcer bleeding. Gastroenterology 108:51, 1995
5 Brunner G, Arnold R, Henning U, Fuchs W: An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Aliment Pharmacol Ther 7(Suppl 1):51–55, 1993
6 Brunner G, Athmann C, Boldt JH: Reversible peripheral edema in female patients taking proton pump inhibitors for peptic acid diseases. Dig Dis Sci 46:993–996, 2001
7 Haeney MR. Angio-oedema and urticaria associated with omeprazole. BMJ 305:870, 1992
8 Odeh M, Lurie M, Oliven A: Cutaneous leucocytoclastic vasculitis associated with omeprazole. Postgrad Med J 78:114–115, 2002
9 Ottervanger JP, Phaff RAS, Vermeulen EGJ, et al.: Anaphylaxis to omeprazole. J Allergy Clin Immunol 97:1413–1414, 1996
10 Katelaris PH. Proton pump inhibitors. Med J Aust 169:208–211, 1998
11 Brunner G, Luna P, Thiesemann C: Drugs for pH control in upper gastrointestinal bleeding. Aliment Pharmacol Ther 9(Suppl 1) 47–50, 1995
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sennaroglu, E., Karakan, S., Kayatas, M. et al. Reversible Edema in a Male Patient Taking Parenteral Pantoprazole Infusion for Pyloric Stenosis. Dig Dis Sci 51, 121–122 (2006). https://doi.org/10.1007/s10620-006-3095-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-3095-1